Synopex (Korea) Performance
| 025320 Stock | KRW 6,320 160.00 2.60% |
The entity has a beta of -0.18, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Synopex are expected to decrease at a much lower rate. During the bear market, Synopex is likely to outperform the market. At this point, Synopex has a negative expected return of -0.31%. Please make sure to validate Synopex's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if Synopex performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Synopex has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -30.4 B |
Synopex |
Synopex Relative Risk vs. Return Landscape
If you would invest 788,000 in Synopex on August 28, 2024 and sell it today you would lose (156,000) from holding Synopex or give up 19.8% of portfolio value over 90 days. Synopex is generating negative expected returns and assumes 3.4426% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Synopex, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Synopex Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Synopex's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Synopex, and traders can use it to determine the average amount a Synopex's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0908
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 025320 |
Estimated Market Risk
| 3.44 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Synopex is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Synopex by adding Synopex to a well-diversified portfolio.
Synopex Fundamentals Growth
Synopex Stock prices reflect investors' perceptions of the future prospects and financial health of Synopex, and Synopex fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Synopex Stock performance.
| Return On Equity | 21.64 | |||
| Return On Asset | -0.0085 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 303.95 B | |||
| Shares Outstanding | 69.6 M | |||
| Price To Earning | 23.11 X | |||
| Price To Sales | 0.79 X | |||
| Revenue | 231.51 B | |||
| EBITDA | 11.3 B | |||
| Cash And Equivalents | 14.22 B | |||
| Cash Per Share | 414.14 X | |||
| Total Debt | 950.69 M | |||
| Debt To Equity | 88.00 % | |||
| Cash Flow From Operations | 6.84 B | |||
| Total Asset | 202.61 B | |||
| Retained Earnings | (20.79 B) | |||
| Current Asset | 68.78 B | |||
| Current Liabilities | 71.12 B | |||
About Synopex Performance
By analyzing Synopex's fundamental ratios, stakeholders can gain valuable insights into Synopex's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Synopex has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Synopex has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Synopex Inc. designs and provides flexible printed circuit board products and IT electronic components in South Korea and internationally. Synopex Inc. was founded in 1985 and is based in Pohang, South Korea. Synopex is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Synopex performance evaluation
Checking the ongoing alerts about Synopex for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Synopex help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Synopex generated a negative expected return over the last 90 days | |
| Synopex has high historical volatility and very poor performance | |
| Synopex has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Synopex has accumulated 950.69 M in total debt with debt to equity ratio (D/E) of 88.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Synopex has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Synopex until it has trouble settling it off, either with new capital or with free cash flow. So, Synopex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Synopex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Synopex to invest in growth at high rates of return. When we think about Synopex's use of debt, we should always consider it together with cash and equity. |
- Analyzing Synopex's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Synopex's stock is overvalued or undervalued compared to its peers.
- Examining Synopex's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Synopex's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Synopex's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Synopex's stock. These opinions can provide insight into Synopex's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Synopex Stock analysis
When running Synopex's price analysis, check to measure Synopex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopex is operating at the current time. Most of Synopex's value examination focuses on studying past and present price action to predict the probability of Synopex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopex's price. Additionally, you may evaluate how the addition of Synopex to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |